Board approves H1 results and incorporation of a wholly-owned subsidiary in Australia
Board approved a wholly-owned subsidiary in Australia, 100% owned.
By ScoutQuest · · 3 min read
- H1 Revenue from operations
- Rs. 3,090.75 lakh (vs 2,228.57 lakh prior year same half)
- H1 Profit after tax
- Rs. 116.68 lakh (vs 185.33 lakh prior year same half)
- Basic and diluted EPS
- Rs. 0.85
The board met on Thursday, 05 November 2026 and approved two things: the unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026, and the incorporation of a Wholly-Owned Subsidiary in Australia.
What was approved
- The unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026, along with the limited review report of the peer reviewed auditor, Timsi & Associates, Chartered Accountants.
- Incorporation of a Wholly-Owned Subsidiary in Australia.
The new subsidiary
- The board has approved incorporation of a wholly-owned subsidiary in Australia, with 100% shareholding. The name will be as approved by the Australian Securities and Investments Commission (ASIC).
- Being newly incorporated, the proposed subsidiary has no operations, turnover or net worth as on date.
- Its objects cover maintaining, managing, promoting, upgrading and expanding educational institutions, centres and colleges on behalf of or as proxy of existing trusts or societies, plus operational support services such as supply chain management, consulting, development, day-to-day management, procurement, accounting and human resource management.
- The update places this in the education-related services sector, which it describes as different from the existing business activities of the company, and says it is meant to explore business opportunities and create a separate platform for education-related activities.
- Consideration and cost of incorporation are stated as "as may be further decided by the board". The process is to be completed on approval by ASIC and completion of necessary statutory updates.
- Upon incorporation it will become a related party of the company under applicable law; the promoters, promoter group and group companies have no interest in the transaction, other than as stated.
Financial results for the half year ended 30 September 2026 (figures as printed, in Rs. lakh):
- Revenue from operations: 3,090.75, against 2,228.57 in the same half of the previous year.
- Profit after tax: 116.68, against 185.33 in the same half of the previous year.
- Basic and diluted earnings per share: 0.85.
Balance sheet highlight
- Cash and cash equivalents stood at 227.86 as at 30 September 2026.
Other points from the notes
- During the period the company incorporated two subsidiaries: Earkart Pharmaceuticals Private Limited in India, a wholly owned subsidiary, and Earkart Health Limited in the United Kingdom, in which the company holds 65% equity shareholding. Both are considered in the consolidated results.
- Shareholders approved a variation in the objects of the Initial Public Offer and the utilisation of unutilised IPO proceeds, with the resolution declared passed as a Special Resolution on 04 May 2026 following remote e-voting that ran from 02 April 2026 to 01 May 2026.
- No investor complaints were received during the half year ended 30 September 2026 and pending as on that date.
How a retail reader can look at it
- The Australian entity is a newly formed company with no operations, turnover or net worth as on date, and the money to be put in is left to the board, so its financial effect will show up only as the business develops.
- The education services activity is described as different from the company's existing hearing-care business, so this is an expansion into a separate line of activity rather than a change to the current one.
- In the half year, revenue was higher than the same half of the previous year, while profit after tax was lower, which is a point to track in the coming periods.
Also from Earkart
Earkart H1 FY27 investor presentation: revenue up 39.42%, EBITDA down 41.94%, PAT down 61.27%
21 Nov 2026
Earkart schedules H1 FY27 earnings call for November 26, 2026 at 4:00 PM IST
21 Nov 2026
US FDA establishment registration and device listing completed for hearing aid products
20 Nov 2026
More numbers
- Revenue from operations, half year ended 30 Sep 20263,090.75 (Rs. In Lakh)
- Revenue from operations, half year ended 30 Sep 20252,228.57 (Rs. In Lakh)
- Profit after tax, half year ended 30 Sep 2026116.68 (Rs. In Lakh)
- Profit after tax, half year ended 30 Sep 2025185.33 (Rs. In Lakh)
- Basic earnings per share, half year ended 30 Sep 20260.85
- Shareholding in proposed Australian subsidiary100%
- Stake in Earkart Health Limited, United Kingdom65%
- Cash and cash equivalents as at 30 Sep 2026227.86 (Rs. In Lakh)
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.